A Phase II, Open-Label Study of Clofarabine in Paediatric Patients With Refractory/Relapsed Acute Lymphoblastic Leukaemia

Vienna

Besançon

Bordeaux

Lille

Lyon

Marseille

Nantes

Paris

Toulouse

Vandœuvre-lès-Nancy

Berlin

Düsseldorf

Frankfurt

Hamburg

Hanover

Kiel

Munich

Münster

Stuttgart

Monza

Pavia

Amsterdam

Groningen

Leiden

Rotterdam

Utrecht

Birmingham

Bristol

Glasgow

Leeds

Liverpool

London

Manchester

Newcastle upon Tyne

Sheffield

Sutton